1. Retrospective analysis of lung cancer patients treated with supportive care alone
- Author
-
Toshihiko Iizasa, Meiji Itakura, Ikuo Sekine, Yasushi Yoshida, Masato Shingyoji, Yoshihiko Sakashita, and Hironori Ashinuma
- Subjects
Adult ,Male ,Narcotics ,medicine.medical_specialty ,Lung Neoplasms ,Palliative care ,03 medical and health sciences ,0302 clinical medicine ,Japan ,Surgical oncology ,Internal medicine ,medicine ,Retrospective analysis ,Humans ,Poor performance status ,030212 general & internal medicine ,Intensive care medicine ,Lung cancer ,Aged ,Retrospective Studies ,business.industry ,Reason for Treatment ,Anti-Inflammatory Agents, Non-Steroidal ,Palliative Care ,Retrospective cohort study ,Hematology ,General Medicine ,Middle Aged ,medicine.disease ,Survival Rate ,Palliative Therapy ,Oncology ,030220 oncology & carcinogenesis ,Female ,Surgery ,business - Abstract
It is not uncommon for patients with lung cancer to receive supportive care alone. However, the clinical characteristics of these patients have not been fully studied. We conducted a retrospective study to identify the clinical characteristics of definitive lung cancer patients treated with supportive care alone. We retrospectively analyzed the percentage of and reasons for definitive lung cancer patients treated with supportive care alone at a regional cancer center. We also investigated the histological diagnostic approaches, palliative therapy types, primary treatment locations after hospital consultation, and places of death. A total of 1,223 patients were histologically diagnosed as having lung cancer between 2011 and 2014. Of these, 160 (13%) patients were treated with supportive care alone. The primary reason for treatment with supportive care alone was a poor performance status (PS) in almost half of the patients. Overall, 40% of the patients received supportive care at home, and 17% were admitted to a palliative care unit (PCU). Death occurred at home for 17% of the patients and in the PCU for 42% of the patients. This study revealed that 13% of histologically proven lung cancer patients were treated with supportive care alone, mostly because of a poor PS. Only 40% of these patients received home care, suggesting the need for a more accessible home care system for patients and their families.
- Published
- 2017